🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gastric or Esophagogastric Junction Adenocarcinoma

Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) NCT05872685Phase 25 sites📍 Hangzhou📍 Hangzhou📍 Lishui Yu jiren · Tests: S1, Oxaliplatin, Serplulimab, Placebo A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma NCT06829797Phase 21 site📍 Jinan Shandong Provincial Hospital · Tests: Neoadjuvant Therapy(QL1706+SOX Chemotherapy), Neoadjuvant Therapy(SOX Chemotherapy), Radical surgery (D2), Drug: Adjuva… Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site📍 Multiple Locations iOMEDICO AG · Tests: Routine care as per site standard First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) NCT06730373Phase 220 sites📍 Zhengzhou📍 Binzhou📍 Dongying Qilu Hospital of Shandong University · Tests: Disitamab Vedotin, Sintilimab, S-1, Trastuzumab, Oxaliplatin A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer NCT05365581Phase 146 sites📍 Orange📍 Santa Monica📍 Chicago Astellas Pharma Global Development, Inc. · Tests: ASP2138, Pembrolizumab, Oxaliplatin, Leucovorin, Fluorouracil KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy NCT05427383Phase 2, Phase 31 site📍 Beijing Shanghai JMT-Bio Inc. · Tests: KN026/Placbo Injection, Paclitaxel Injection, Docetaxel Injection, Irinotecan Injection A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer NCT07631000Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cadonilimab Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma NCT07643623Phase 2, Phase 31 site📍 Guangzhou Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Tests: tegafur, Gimeracil and Oteracil Potassium Capsules, Sintilimab Placebo, Sintilimab, Ipilimumab N01, Oxaliplatin for inj… Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer NCT03219593Phase 21 site📍 Bengbu The First Affiliated Hospital of Bengbu Medical University · Tests: Apatinib mesylate tablets Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. NCT06773312Phase 11 site📍 Beijing Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. · Tests: BC001+Sintilimab+XELOX Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) NCT07432295Phase 26 sites📍 Goodyear📍 Duarte📍 Boston I-Mab Biopharma US Limited · Tests: Givastomig, Nivolumab, 5Fluorouracil, Leucovorin, Oxaliplatin Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC NCT06023758Phase 21 site📍 Beijing Peking University · Tests: KN026, KN046, XELOX Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ Adenocarcinoma NCT07569068Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Tislelizumab, LM-302 and S-1, Tislelizumab combined with oxaliplatin and S-1 DBC-664 in Adult Patients With Solid Tumors NCT07705035Phase 16 sites📍 Denver📍 Grand Rapids📍 East Brunswick Duboce Biopharmaceuticals, Inc. · Tests: DBC-664 A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Miami Astellas Pharma Global Development, Inc. · Tests: ASP546C A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma NCT06341335Phase 31 site📍 Beijing Akeso · Tests: cadonilimab, pulocimab, paclitaxel, placebo Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer NCT05640609Phase 1, Phase 21 site📍 Chengdu West China Hospital · Tests: Capeox regimen combined with Sintilimab and Bevacizumab QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ NCT07716449Phase 31 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: QLS31905, Sintilimab, Oxaliplatin, Capecitabine A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144Phase 130 sites📍 Tucson📍 Duarte📍 Aurora Coherus Oncology, Inc. · Tests: CHS-114, Toripalimab, 5 Fluorouracil, Cisplatin A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer NCT06776770Phase 1, Phase 21 site📍 Shenzhen Cancer Hospital Chinese Academy of Medical Science, Shenzhe… · Tests: Adebrelimab A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma NCT07069712Phase 270 sites📍 Newark📍 Washington D.C.📍 Fairway AstraZeneca · Tests: Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd), Capecitabine, 5-Fluorouracil (5-FU) Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma NCT05960955Phase 21 site📍 Tianjin Akeso · Tests: Cadonilimab, AK117, Oxaliplatin, Tegafur-gimeracil-oteracil potassium, Docetaxel SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure NCT07311408Phase 21 site📍 Shenyang Jingdong Zhang · Tests: SHR-1701+Rivoceranib + SHR-2554, SHR-1701 + Rivoceranib IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer NCT07025889Phase 1, Phase 21 site📍 Shanghai Ruijin Hospital · Tests: IBI343, Sintilimab, Oxaliplatin, S-1 Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC NCT04342910Phase 31 site📍 Beijing Jiangsu HengRui Medicine Co., Ltd. · Tests: camrelizumab, Apatinib Mesylate, Paclitaxel, Irinotecan T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma NCT05894824Phase 1, Phase 21 site📍 Seoul Yonsei University · Tests: T-Dxd(Trastuzmab deruxtecan), Ramucirumab JS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma NCT07584135Phase 31 site📍 Guangzhou NingBo Junyan Hongshi Biosciences Co., Ltd · Tests: Injection JS107&Toripalimab& Oxaliplatin Injection& Capecitabine, Sintilimab& Oxaliplatin Injection&… LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study NCT07556640Phase 21 site📍 Shanghai Ruijin Hospital · Tests: LM-302, S-1, paclitaxel, LM-302, Cadonilimab, S-1, paclitaxel A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma NCT04982276Phase 1, Phase 21 site📍 Beijing Akeso · Tests: AK109, paclitaxel, paclitaxel, AK104
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy